106 related articles for article (PubMed ID: 33361583)
1. Integrative analysis of transcriptional profile reveals LINC00052 as a suppressor of breast cancer cell migration.
Sanchez-Lopez JM; Mandujano-Tinoco EA; Garcia-Venzor A; Lozada-Rodriguez LF; Zampedri C; Uribe-Carvajal S; Melendez-Zajgla J; Maldonado V; Lizarraga F
Cancer Biomark; 2021; 30(4):365-379. PubMed ID: 33361583
[TBL] [Abstract][Full Text] [Related]
2. Changes in the transcriptome profile of breast cancer cells grown as spheroids.
Muñoz-Galindo L; Melendez-Zajgla J; Pacheco-Fernández T; Rodriguez-Sosa M; Mandujano-Tinoco EA; Vazquez-Santillan K; Castro-Oropeza R; Lizarraga F; Sanchez-Lopez JM; Maldonado V
Biochem Biophys Res Commun; 2019 Sep; 516(4):1258-1264. PubMed ID: 31301772
[TBL] [Abstract][Full Text] [Related]
3. Decoding LINC00052 role in breast cancer by bioinformatic and experimental analyses.
Sanchez-Lopez JM; Juarez-Mancera MA; Bustamante B; Ruiz-Silvestre A; Espinosa M; Mendoza-Almanza G; Ceballos-Cancino G; Melendez-Zajgla J; Maldonado V; Lizarraga F
RNA Biol; 2024 Jan; 21(1):1-11. PubMed ID: 38832821
[TBL] [Abstract][Full Text] [Related]
4. LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer.
Xiong X; Shi Q; Yang X; Wang W; Tao J
J Cell Physiol; 2019 Sep; 234(9):15619-15626. PubMed ID: 30712321
[TBL] [Abstract][Full Text] [Related]
5. HER3 and LINC00052 interplay promotes tumor growth in breast cancer.
Salameh A; Fan X; Choi BK; Zhang S; Zhang N; An Z
Oncotarget; 2017 Jan; 8(4):6526-6539. PubMed ID: 28036286
[TBL] [Abstract][Full Text] [Related]
6. LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma.
Lin J; Nong LL; Li MQ; Yang FC; Wang SH; Liu MJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4673-4679. PubMed ID: 31210293
[TBL] [Abstract][Full Text] [Related]
7. LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma.
Yan S; Shan X; Chen K; Liu Y; Yu G; Chen Q; Zeng T; Zhu L; Dang H; Chen F; Ling J; Huang A; Tang H
Gene; 2018 Dec; 679():138-149. PubMed ID: 30098428
[TBL] [Abstract][Full Text] [Related]
8. LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration.
Xiong D; Sheng Y; Ding S; Chen J; Tan X; Zeng T; Qin D; Zhu L; Huang A; Tang H
Oncotarget; 2016 Jul; 7(30):47593-47608. PubMed ID: 27351280
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LINC00052 suppressed the proliferation, migration and invasion of glioma cells by upregulating KLF6.
Xu CF; Liu P; Tan J; Hu DF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4822-4827. PubMed ID: 31210314
[TBL] [Abstract][Full Text] [Related]
10. LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p.
Zhu L; Yang N; Chen J; Zeng T; Yan S; Liu Y; Yu G; Chen Q; Du G; Pan W; Li X; Zhou H; Huang A; Tang H
Oncotarget; 2017 Sep; 8(38):63724-63737. PubMed ID: 28969024
[TBL] [Abstract][Full Text] [Related]
11. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome profile of the early stages of breast cancer tumoral spheroids.
Pacheco-Marín R; Melendez-Zajgla J; Castillo-Rojas G; Mandujano-Tinoco E; Garcia-Venzor A; Uribe-Carvajal S; Cabrera-Orefice A; Gonzalez-Torres C; Gaytan-Cervantes J; Mitre-Aguilar IB; Maldonado V
Sci Rep; 2016 Mar; 6():23373. PubMed ID: 27021602
[TBL] [Abstract][Full Text] [Related]
13. LINC00052 Promotes Gastric Cancer Cell Proliferation and Metastasis via Activating the Wnt/β-Catenin Signaling Pathway.
Shan Y; Ying R; Jia Z; Kong W; Wu Y; Zheng S; Jin H
Oncol Res; 2017 Nov; 25(9):1589-1599. PubMed ID: 28337962
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.
Liu X; Tian X
Med Sci Monit; 2021 Mar; 27():e929832. PubMed ID: 33716295
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells.
Shi Y; Lu J; Zhou J; Tan X; He Y; Ding J; Tian Y; Wang L; Wang K
Biochem Biophys Res Commun; 2014 Apr; 446(2):448-53. PubMed ID: 24631686
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
17. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
Xu F; Li H; Hu C
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
[TBL] [Abstract][Full Text] [Related]
18. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
Sun L; Li Y; Yang B
Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
[TBL] [Abstract][Full Text] [Related]
19. LINC00052 promotes breast cancer cell progression and metastasis by sponging miR-145-5p to modulate TGFBR2 expression.
Dong M; Xu T; Li H; Li X
Oncol Lett; 2021 May; 21(5):368. PubMed ID: 33777194
[TBL] [Abstract][Full Text] [Related]
20. Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Tracy KM; Tye CE; Page NA; Fritz AJ; Stein JL; Lian JB; Stein GS
J Cell Physiol; 2018 Feb; 233(2):1291-1299. PubMed ID: 28488769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
